Filing Details

Accession Number:
0000919574-25-001031
Form Type:
13G Filing
Publication Date:
2025-02-11 19:00:00
Filed By:
Sofinnova Investments, Inc.
Company:
Marinus Pharmaceuticals Inc. (NASDAQ:MRNS)
Filing Date:
2025-02-12
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Sofinnova Investments, Inc. 0 0 0.0%
Sofinnova BioEquities GP LLC 0 0 0.0%
James Healy 0 0 0.0%
Eric Delbridge 0 0 0.0%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Sofinnova Investments, Inc.
 
Signature:By: /s/ James Healy
Name/Title:James Healy / Director
Date:02/12/2025
 
Sofinnova BioEquities GP LLC
 
Signature:By: /s/ Eric Delbridge
Name/Title:Eric Delbridge / Managing Member
Date:02/12/2025
 
James Healy
 
Signature:By: /s/ James Healy
Name/Title:James Healy
Date:02/12/2025
 
Eric Delbridge
 
Signature:By: /s/ Eric Delbridge
Name/Title:Eric Delbridge
Date:02/12/2025

Comments accompanying signature:  * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose. To the extent that "ownership of 5 percent or less of a class" was indicated in Item 5, such response only applies to the Reporting Person(s) that indicated elsewhere herein that it beneficially owns five percent (5%) or less of the class.
Exhibit Information

[Exhibit A - Joint Filing Agreement] [Exhibit B - Control Person Identification]